Nuvectis Pharma, Inc. (NVCT) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$8.72
Day's range
$9.14

Nuvectis Pharma Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
TANG CAPITAL MANAGEMENT LLC 08/14/2026 1.55 M $28.50 M   100.00% 6.60%
BLACKROCK, INC. 08/07/2026 1.00 M $18.41 M   30.98% 4.27%
PERCEPTIVE ADVISORS LLC 08/14/2026 1.00 M $18.39 M   100.00% 4.26%
SOLEUS CAPITAL MANAGEMENT, L.P. 08/11/2026 1.00 M $18.39 M   100.00% 4.26%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 872.48 K $16.04 M   32.22% 3.72%
IRIDIAN ASSET MANAGEMENT LLC/CT 07/29/2026 777.08 K $14.29 M   19.23% 3.31%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 432.27 K $7.95 M   12.54% 1.84%
SPHERA FUNDS MANAGEMENT LTD. 08/14/2026 382.95 K $7.04 M   100.00% 1.63%
BALDWIN BROTHERS LLC/MA 07/14/2026 382.02 K $7.03 M   0.90% 1.63%
OCCAM CREST MANAGEMENT LP 08/14/2026 357.15 K $7.39 M   -12.28% 1.52%
ALYESKA INVESTMENT GROUP, L.P. 08/14/2026 275.00 K $5.06 M   100.00% 1.17%
STATE STREET CORP 08/07/2026 248.20 K $4.56 M   49.05% 1.06%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 217.29 K $4.00 M   106.38% 0.93%
AVIDITY PARTNERS MANAGEMENT LP 08/14/2026 200.00 K $3.68 M   100.00% 0.85%
CAPTION MANAGEMENT, LLC 08/14/2026 160.30 K $2.95 M   100.00% 0.68%
NORTHERN TRUST CORP 08/13/2026 146.71 K $2.70 M   18.12% 0.63%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 127.55 K $2.35 M   11.07% 0.54%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 118.30 K $2.18 M   28.37% 0.50%
CITADEL ADVISORS LLC 09/02/2026 115.53 K $2.12 M   47.32% 0.49%
KALEHUA CAPITAL MANAGEMENT LLC 08/19/2026 100.00 K $1.84 M   100.00% 0.43%
JANE STREET GROUP, LLC 08/14/2026 82.30 K $1.51 M   347.28% 0.35%
OPPENHEIMER & CO INC 08/03/2026 73.57 K $1.35 M   0.00% 0.31%
UBS GROUP AG 08/13/2026 69.20 K $1.27 M   79.45% 0.29%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 68.00 K $1.25 M   100.00% 0.29%
CIBC BANCORP USA INC. 08/13/2026 67.16 K $917.66 K   161.69% 0.29%
FORBES J M & CO LLP 07/20/2026 59.00 K $1.09 M   0.00% 0.25%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 57.13 K $1.05 M   15.08% 0.24%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 57.13 K $1.05 M   100.00% 0.24%
CITADEL ADVISORS LLC 09/02/2026 51.00 K $937.89 K   100.00% 0.22%
EAM INVESTORS, LLC 08/13/2026 47.17 K $867.42 K   100.00% 0.20%
NUVEEN, LLC 08/11/2026 40.82 K $750.74 K   143.73% 0.17%
STONEPINE CAPITAL MANAGEMENT, LLC 08/17/2026 40.00 K $735.60 K   100.00% 0.17%
SQUADRON CAPITAL MANAGEMENT LLC 08/14/2026 38.70 K $711.69 K   100.00% 0.16%
BANK OF NEW YORK MELLON CORP 08/06/2026 36.77 K $676.19 K   21.29% 0.16%
AQR CAPITAL MANAGEMENT LLC 08/14/2026 31.89 K $586.39 K   100.00% 0.14%
SIMPLEX TRADING, LLC 08/12/2026 31.39 K $577.34 K   1,109.32% 0.13%
SEI INVESTMENTS CO 08/14/2026 27.96 K $514.24 K   100.00% 0.12%
STRS OHIO 07/30/2026 27.20 K $500.21 K   100.00% 0.12%
JANE STREET GROUP, LLC 08/14/2026 26.40 K $485.50 K   100.00% 0.11%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 25.10 K $461.59 K   100.00% 0.11%
SHAY CAPITAL LLC 08/14/2026 21.00 K $386.19 K   100.00% 0.09%
GOLDMAN SACHS GROUP INC 08/14/2026 20.48 K $376.63 K   -50.20% 0.09%
AUSTIN WEALTH MANAGEMENT, LLC 07/22/2026 20.13 K $385.19 K   0.00% 0.09%
DAFNA CAPITAL MANAGEMENT LLC 08/14/2026 20.00 K $367.80 K   100.00% 0.09%
MORGAN STANLEY 08/13/2026 18.72 K $344.28 K   -17.05% 0.08%
MARTINGALE ASSET MANAGEMENT L P 08/13/2026 18.02 K $331.46 K   0.00% 0.08%
RHUMBLINE ADVISERS 08/12/2026 17.27 K $317.61 K   99.50% 0.07%
DEUTSCHE BANK AG\ 08/07/2026 16.87 K $310.31 K   33.16% 0.07%
CITADEL ADVISORS LLC 09/02/2026 15.70 K $288.72 K   100.00% 0.07%
WELLS FARGO & COMPANY/MN 08/14/2026 15.59 K $286.77 K   177.52% 0.07%

Nuvectis Pharma Inc institutional Ownership - FAQ's

During the previous two years, 97 institutional investors and hedge funds held shares of Nuvectis Pharma Inc. The most heavily invested institutionals were:

TANG CAPITAL MANAGEMENT LLC: 1.55 M

BlackRock, Inc.: 1 M

Soleus Capital Management, L.P.: 1,000,000

PERCEPTIVE ADVISORS LLC: 1,000,000

VANGUARD CAPITAL MANAGEMENT LLC: 872,482

IRIDIAN ASSET MANAGEMENT LLC/CT: 777,078

43.88% of Nuvectis Pharma Inc stock is owned by institutional investors.

Institutional investors have bought a total of 11.81 M shares in the last 24 months. This purchase volume represents approximately $107.21 M in transactions.